Increases in Adult Life Expectancy in Rural South Africa: Valuing the Scale-Up of HIV Treatment

Author:

Bor Jacob12,Herbst Abraham J.1,Newell Marie-Louise13,Bärnighausen Till12

Affiliation:

1. Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Post Office Box 198, Mtubatuba, KwaZulu-Natal 3935, South Africa.

2. Harvard School of Public Health, Harvard University, 677 Huntington Avenue, Boston, MA 02115, USA.

3. Institute of Child Health, University College London, 30 Guilford Street, London WC1N 1EH, UK.

Abstract

Cost-Benefit of ART In the battle to control HIV, mass antiretroviral treatment (ART) costs $500 to $900 per person per year. Bor et al. (p. 961 ) calculated the impact of intensifying ART on the life expectancy of people living in rural KwaZulu Natal. The dates of death were collected from a population of about 100,000 people during 2000–2011: Four years before and 8 years after the scaling up of ART. Life expectancy of adults increased by more than 11 years after ART was expanded, and the economic value of the lifetimes gained were calculated to far exceed the cost of treatment. Tanser et al. (p. 966 ) followed nearly 17,000 HIV-uninfected individuals in KwaZulu-Natal over an 8-year period. Holding other HIV risk factors constant, individual HIV acquisition risk declined significantly with increasing ART coverage of HIV-infected people.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference58 articles.

1. United Nations Department of Economic and Social Affairs Population Division World Population Prospects: The 2010 Revision (CD-ROM Edition 2011).

2. WHO World Health Statistics 2012. Life Tables for WHO Member States ; and methodological appendix Life Tables for 2009 2000 and 1990: Summary of Data and Methods Used (WHO Geneva Switzerland 2012).

3. Global AIDS Epidemic: Time to Turn the Tide

4. T. Barnett A. Whiteside AIDS in the Twenty-First Century: Disease and Globalization (Palgrave Macmillan New York 2002).

5. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3